Longeveron Company
We are a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. Through patient-focused, regenerative medicine, our research and therapies are aimed at improving healthspan.
Founded Date:
2014
Total Funding:
8.99997
Investor Type:
For Profit
Employee Number:
20
Funding Status:
IPO
Number Of Exists:
11-50
Technology:
Regenerative Medicine
Last Funding Type:
Grant
Investors Number:
3
Industry:
Cellular therapy
Headquarters:
Miami
Estimated Revenue:
$1M to $10M